News

November 7, 2019November 7, 2019

Ambroxol Plus ERT Is Safe, Could Halt Neurological Progression in Gaucher, Small Study Suggests

News

Oral treatment with ambroxol — an investigational chaperone therapy — plus enzyme replacement therapy (ERT) was found to be safe over a course of 4.5 years, and helped partially restore ... Read more

November 4, 2019November 4, 2019

New Test May Help Select Gaucher Patients Best Suited for Chaperone Therapy, Study Suggests

News

A laboratory test using blood samples could help identify Gaucher disease (GD) patients likely to respond to experimental chaperone therapies, a study reports. The assay is based on macrophages, white blood ... Read more

October 31, 2019October 31, 2019

FDA Grants Orphan Designation to AVR‑RD‑02 Gene Therapy for Gaucher Disease

News

The U.S. Food and Drug Administration (FDA) granted orphan drug designation to AVR-RD-02, a gene therapy candidate for the treatment of Gaucher disease. AVR‑RD‑02, being developed by Avrobio, recently advanced to ... Read more

October 28, 2019October 28, 2019

Bone Manifestations Highly Common in Gaucher, Long-term Study Finds

News

Bone problems are highly common among people with Gaucher disease, with symptoms including chronic bone pain, death of bone tissue due to insufficient blood supply to bones, and fractures, a ... Read more

October 24, 2019October 24, 2019

Prevail and Lonza Join Forces to Develop PR001 Gene Therapy for Gaucher Type 2

News

Prevail Therapeutics and Lonza Pharma & Biotech will collaborate in the development and production of Prevail’s PR001 gene therapy for children with type 2 Gaucher disease and for select patients with Parkinson’s disease, ... Read more

October 21, 2019

‘Collodion’ Skin Disorder in Newborn Early Sign of Severe Perinatal Type 2 Gaucher, Case Study Suggests

News

Infants who are born encased in a tight and shiny membrane made of skin cells that resembles plastic wrap, and commonly called “collodion babies,” may have severe perinatal (fetal) Gaucher ... Read more

October 10, 2019

Gaucher Disease Might Be Associated with Rare Types of Blood Cancer, Case Report Suggests

News

Gaucher disease can predispose patients to rare types of blood cancer, and doctors should be vigilant for the development of these malignancies, a case report suggests. The study, “A case ... Read more

October 8, 2019October 17, 2019

Screening for Multiple Myeloma and Other Blood Cell Disorders May Be Useful with Gaucher, Study Says

News

Gaucher disease is not common in people with a group of disorders called plasma cell dyscrasias (PCDs), which include multiple myeloma. But screening for these disorders among Gaucher patients could be ... Read more

October 7, 2019

New Fly Model of Gaucher Disease May Improve Knowledge of Disease Mechanisms, Researchers Say

News

A new fly model of Gaucher disease may more fully summarize and present the molecular complexities of the disease in humans than other animal models do, researchers say. This recapitulated ... Read more

October 3, 2019

Pilot Study Demonstrates Feasibility of Gaucher Monitoring with Cell Phones

News

Mobile phone-based monitoring may allow for better measurement of how Gaucher disease affects the lives of those who have it, a new pilot study reports. The investigators suggest that such ... Read more